Efficacy and Safety of Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity

Inclusion Criteria: * 1\) Age: 18-60 years old (inclusive); Gender: male or female. * 2\) Body Mass Index (24.0≤BMI≤40.0 kg/m²). * 3\) Has no taken any medications for metabolic control (e.g., for body weight, blood lipids, or blood glucose) within the past month. * 4\) Has been attempting to manage weight primarily through lifestyle interventions (diet and exercise) for at least one month prior to screening. * 5\) Processes adequate communication and cognitive abilities, is expected to be compliant with long-term medication, and has understood the nature, significance, potential benefits, inconveniences, and risks of the study prior to enrollment. * 6\) For participants of childbearing potential (male or female): Must agree to use at least one medically approved form of contraception (e.g., intrauterine device \[IUD\], oral contraceptives, or condoms) throughout the trial. For female participants of childbearing potential: Must have a negative serum pregnancy test at screening and must be non-lactating. * 7\) Voluntarily agrees to participate by signing the inform consent form and commits to follow the trial treatment plan and visit schedule. Exclusion Criteria: * 1\) A clear history of neurological or psychiatric disorders (including epilepsy and dementia). * 2\) Hyperlipidemia due to secondary causes, such as nephrotic syndrome, hepatic diseases, hypothyroidism, or renal failure. * 3\) Concurrent severe medical conditions deemed by the investigator to require immediate …